Gram-stained smear in the diagnosis of acute urethritis: is it coming to an end?

Acute urethritis is the most common infection of the male genital tract. Approximately 89 million new cases of non-gonococcal urethritis (NGU) and 62 million new cases of gonococcal urethritis (GU) are reported globally every year, and these numbers continue to increase¹. Acute urethritis is most commonly caused by sexually transmitted pathogens. The three cardinal symptoms are urethral discharge, dysuria, and itching. The traditional diagnostic method for acute urethritis is a Gram-stained smear (GSS) of urethral discharge. GSS is widely used because it is of low cost and is easy to perform. Not only does GSS diagnose acute urethritis but it also allows the dichotomization of cases as GU caused by Neisseria gonorrhoeae with the detection of gram-negative diplococci or NGU in their absence². However, GSS is a test susceptible to inter- and intra-observer errors.

In the classical approach, the treatment of acute urethritis is managed through GSS. GSS inevitably leads the clinician to empirical treatment, especially in cases of NGU, as the specific identification of NGU pathogens by conventional methods is a long process. However, treatment failure occurs in up to 20% of NGU patients who receive empirical treatment based on the results of GSS³. Moreover, empirical treatment practices also contribute to the development of resistant strains. Antibiotic resistance in N. gonorrhoeae and Mycoplasma genitalium is a serious public health problem⁴, and M. genitalium alone is responsible for 41% of recurrent urethritis cases⁵.

The widespread use of nucleic acid amplification tests such as polymerase chain reaction (PCR) has brought about significant advances in the management of acute urethritis⁶. PCR enables the rapid identification of multiple pathogens from a single sample with high sensitivity and specificity and has become the gold standard for identifying urethritis pathogens⁷. PCR also allowed inquiry into the effectiveness of GSS. The inability of GSS to detect coinfections of NGU pathogens with GU is an important limitation. GSS is also ineffective in urethritis patients with low inflammation, some of whom may even be asymptomatic. In a recently published study, 68.7% of urethritis cases evaluated by PCR did not have apparent urethral discharge, making it difficult to detect these cases with GSS⁸. This results in misdiagnosis and patients continuing to act as a vector of the contagion.

Traditionally, the threshold for GSS is ≥5 polymorphonuclear leucocytes (PMNL)/high-power field (HPF)⁹. However, a PCR confirmation study demonstrated that GSS had 55.6% sensitivity in the diagnosis of NGU when using a threshold of ≥5 PMNL/HPF in cases of acute urethritis¹⁰. Current guidelines recommend a GSS threshold of ≥2 PMNL/HPF for the diagnosis of NGU¹¹. Considering that the frequency of NGU pathogens in acute urethritis is above 80%¹², GSS may be seriously inadequate in identifying the majority of acute urethritis cases.

In terms of cost, GSS and PCR are not comparable at present. However, the risks of misdiagnosis, antibiotic resistance, and recurrent urethritis associated with GSS warrant a critical scrutiny of its cost-effectiveness. In our view, GSS has fulfilled its role in the diagnosis of acute urethritis. Going forward, PCR assay should be regarded as the first choice for both the diagnosis of acute urethritis and the identification of causative pathogens. In our view, this is, first and foremost, the right approach for public health.

• Funding: none.

REFERENCES

• ¹
  McKechnie ML, Hillman R, Couldwell D, Kong F, Freedman E, Wang H, et al. Simultaneous identification of 14 genital microorganisms in urine by use of a multiplex PCR-based reverse line blot assay. J Clin Microbiol. 2009;47(6):1871-7. https://doi.org/10.1128/JCM.00120-09
  » https://doi.org/10.1128/JCM.00120-09
• ²
  Sarier M. Prevalence of polymicrobial infection in urethritis. J Urol Surg. 2019;6(3):180-3. https://doi.org/10.4274/jus.galenos.2019.2405
  » https://doi.org/10.4274/jus.galenos.2019.2405
• ³
  Manhart LE, Gillespie CW, Lowens MS, Khosropour CM, Colombara DV, Golden MR, et al. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis. 2013;56(7):934-42. https://doi.org/10.1093/cid/cis1022
  » https://doi.org/10.1093/cid/cis1022
• ⁴
  Iwuji C, Pillay D, Shamu P, Murire M, Nzenze S, Cox LA, et al. A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa. J Antimicrob Chemother. 2022;77(8):2074-93. https://doi.org/10.1093/jac/dkac159
  » https://doi.org/10.1093/jac/dkac159
• ⁵
  Wikström A, Jensen JS. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect. 2006;82(4):276-9. https://doi.org/10.1136/sti.2005.018598
  » https://doi.org/10.1136/sti.2005.018598
• ⁶
  Sarier M. Polymerase chain reaction assay in acute urethritis. Andrologia. 2019;51(8):e13366. https://doi.org/10.1111/and.13366
  » https://doi.org/10.1111/and.13366
• ⁷
  Sarier M, Sepin N, Emek M, Germen AT, Hoscan MB, Konuk E, et al. Evaluating the utility of the A.F. genital system test for pathogen diagnosis in acute male urethritis. Andrologia. 2022;54(4):e14377. https://doi.org/10.1111/and.14377
  » https://doi.org/10.1111/and.14377
• ⁸
  Sarier M, Demir M, Turgut H, Hizel A, Emek M, Kukul E, et al. New approach to microscopy of gram-stained urethral smear: the kissing slide method. Sex Transm Dis. 2020;47(10):712-5. https://doi.org/10.1097/OLQ.0000000000001228
  » https://doi.org/10.1097/OLQ.0000000000001228
• ⁹
  Sarier M, Duman İ, Göktaş Ş, Demir M, Kukul E. Results of multiplex polymerase chain reaction assay to identify urethritis pathogens. J Urol Surg. 2017;4(1):18-22. https://doi.org/10.4274/jus.1328
  » https://doi.org/10.4274/jus.1328
• ¹⁰
  Sarier M, Sepin N, Duman I, Demir M, Hizel A, Göktaş Ş, et al. Microscopy of gram-stained urethral smear in the diagnosis of urethritis: which threshold value should be selected? Andrologia. 2018;50(10):e13143. https://doi.org/10.1111/and.13143
  » https://doi.org/10.1111/and.13143
• ¹¹
  Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-87. https://doi.org/10.15585/mmwr.rr7004a1
  » https://doi.org/10.15585/mmwr.rr7004a1
• ¹²
  Rossignol L, Feuillepain L, Ndeikoundam Ngangro N, Souty C, Fournet N, Strat Y, et al. Estimate of male urethritis incidences in France between 2007 and 2017 with a specific focus on Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis infections. BMC Infect Dis. 2019;19(1):561. https://doi.org/10.1186/s12879-019-4202-1
  » https://doi.org/10.1186/s12879-019-4202-1

Publication Dates

• Publication in this collection
  22 Apr 2024
• Date of issue
  2024

History

• Received
  08 Nov 2023
• Accepted
  16 Nov 2023